Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children
- PMID: 15940440
- DOI: 10.1007/s00392-005-0246-x
Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children
Abstract
Background: N-terminal brain natriuretic peptide (NT-proBNP) is a neurohormonal substance secreted mainly by the cardiac myocytes of the left ventricle and to a less degree of the left atrium. The releasing mechanism is induced by an increased wall stress on the base of volume or pressure load of the ventricle. The physiologic actions of BNP are prohibition of the sympathetic activity, vasodilatation, natriuresis, diureses and inhibition of the renin-angiotensin system. Because of its high sensitivity and specifity in relation to the left ventricular incompetence, BNP as well as NTproBNP are well accepted markers of ventricular dysfunction. It was the aim of the study to establish reference values of NT-proBNP serum concentrations throughout childhood, in particular in the newborn age group.
Methods: In a cross sectional study, serum NT-proBNP concentrations were measured by an ElectroChemiLuminescenceImmunoAssay ("ECLIA" Roche) in the umbilical cord blood of 62 healthy full-term neonates and in 222 healthy probands from birth up to the age of 18 years.
Results: The concentration of NT-proBNP in the cord blood samples ranged from 281 to 2595 pg/ml (mean: 818 pg/ml). There was a significant increase in the first days of life followed by a rapid decrease during the first year and a further gradual decrease throughout infancy; beyond the 10(th) year of age normal adult values were approached.
Conclusions: The knowledge of the normal range of plasma NT-proBNP levels in healthy subjects during childhood serves as a non-invasive marker for differentiation of pathologic conditions such as acute myocarditis, hypertrophic or dilated cardiomyopathy, tachyarrhythmias and pulmonary hypertension.
Similar articles
-
Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.Rev Port Cardiol. 2004 Dec;23(12):1557-82. Rev Port Cardiol. 2004. PMID: 15732658 English, Portuguese.
-
NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.Pediatr Cardiol. 2006 Jan-Feb;27(1):87-90. doi: 10.1007/s00246-005-1027-z. Pediatr Cardiol. 2006. PMID: 16132296
-
N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.Clin Lab. 2005;51(3-4):167-72. Clin Lab. 2005. PMID: 15819172
-
Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.Semin Vasc Surg. 2014 Dec;27(3-4):143-7. doi: 10.1053/j.semvascsurg.2015.01.004. Epub 2015 Jan 21. Semin Vasc Surg. 2014. PMID: 26073822 Review.
-
NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.Pediatr Cardiol. 2009 Jan;30(1):3-8. doi: 10.1007/s00246-008-9258-4. Epub 2008 Jul 4. Pediatr Cardiol. 2009. PMID: 18600369 Review.
Cited by
-
B-Type Cardiac Natriuretic Peptides in the Neonatal and Pediatric Intensive Care Units.J Pediatr Intensive Care. 2016 Dec;5(4):189-197. doi: 10.1055/s-0036-1583543. Epub 2016 May 4. J Pediatr Intensive Care. 2016. PMID: 31110904 Free PMC article. Review.
-
The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.Pediatr Rheumatol Online J. 2019 Sep 18;17(1):65. doi: 10.1186/s12969-019-0368-8. Pediatr Rheumatol Online J. 2019. PMID: 31533770 Free PMC article.
-
Changes in Internal Cerebral Vein Pulsation and Intraventricular Hemorrhage in Extremely Preterm Infants.Am J Perinatol. 2024 May;41(S 01):e37-e45. doi: 10.1055/a-1817-6638. Epub 2022 Apr 5. Am J Perinatol. 2024. PMID: 35381610 Free PMC article.
-
Newborn Screening for High-Risk Congenital Heart Disease by Dried Blood Spot Biomarker Analysis.JAMA Netw Open. 2024 Jun 3;7(6):e2418097. doi: 10.1001/jamanetworkopen.2024.18097. JAMA Netw Open. 2024. PMID: 38913376 Free PMC article.
-
Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment.Arch Gynecol Obstet. 2024 Apr;309(4):1341-1351. doi: 10.1007/s00404-023-07006-8. Epub 2023 Mar 26. Arch Gynecol Obstet. 2024. PMID: 36966429 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials